Telemedicine for Improving Outcome in Inner City Patient Population With Hypercapneic Respiratory Failure (ETOUCH)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03353064 |
|
Recruitment Status :
Terminated
(inability to recruit subjects)
First Posted : November 27, 2017
Last Update Posted : October 29, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The Hypercapnia Telemedicine Outreach Program (E-TOUCH Study) aims to utilize telemedicine technology, as well as emergency medical services (EMS) home visits to address the problem with poor follow-up and compliance among Einstein's hypercapnic patients.
The hypothesis is that reaching out to the subjects' homes will allow more consistent healthcare delivery, increase healthcare efficiency and compliance with therapy, and overall decrease acute decompensated states / hypercapnic respiratory failure, decreasing ED visits and hospitalization.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Hypercapnic Respiratory Failure Chronic Obstructive Pulmonary Disease Obesity Hypoventilation Syndrome Sleep Disordered Breathing Neuromuscular Diseases | Other: Vivify Other: EMS | Not Applicable |
Hypercapnic respiratory failure is a prevalent medical problem, comprising a substantial number of ED visits and readmissions. The target population that are at high risk for developing hypercapnia are patients with obesity hypoventilation syndrome (OHS), chronic obstructive pulmonary disease (COPD), sleep disordered breathing (SDB) overlapping with COPD, and patients with neuromuscular disorders. These patients are commonly managed in the progressive care units or the intensive care unit for extended periods of time, which can over-utilize health systems resources. Einstein Medical Center's patient population includes multiple low-income communities / neighborhoods. Their educational background varies and constant education and counseling is an integral part of the treatment plan. These patients are particularly vulnerable due to a lack of geographic access and difficulty contacting healthcare providers via phone. Some of the patients may not be able to afford co-pays for clinic visits or are not able to follow up with a physician. In addition, patients treated with non-invasive ventilation in the hospital and require home therapy either never receive the device or are sub-optimally trained in its appropriate utilization. These patients may also be morbidly obese with mobility issues, which is another obstacle preventing patients from following up with their providers.
Positive airway pressure (PAP) therapy/ non-invasive positive pressure ventilation (NIPPV) are effective treatments to avoid acute hypercapnic respiratory failure; however, low compliance and poor follow-up are often recurring issues. These high-risk patients present in the emergency department acutely hypercapnic and encephalopathic with subsequent ICU admission and mechanical ventilation.This Telemedicine Outreach Program aims to utilize E-touch devices (Vivify-Go) in collaboration with home visits by EMS (Emergency medical services) to improve compliance and the efficiency of healthcare delivery. These efforts will hopefully lead to a decrease in acute decompensated respiratory states and hospital readmission rates.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 4 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Randomized Controlled Trial |
| Masking: | Single (Outcomes Assessor) |
| Masking Description: | Statisticians will be receiving de-identified data |
| Primary Purpose: | Health Services Research |
| Official Title: | Telemedicine as a Proposed Solution Towards Efficiency of Healthcare Delivery for Einstein Pulmonary Patients on PAP/NIPPV for Hypercapnia |
| Actual Study Start Date : | October 18, 2017 |
| Actual Primary Completion Date : | October 26, 2018 |
| Actual Study Completion Date : | October 26, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Vivify + EMS
This arm will have the Telemedicine kits and get scheduled EMS home visits. The subjects will complete daily biometrics / surveys / care plans through the telemedicine kit, as specified in the activity schedule Apart from the tablet device, EMS home visits will be scheduled on Day 7, Day 21 and Day 42 from discharge. During these home visits, the EM personnel will perform a check of the NIV/NIPPV device. They are able to adjust pressures according to your Pulmonologist / Sleep doctor's prescription, and troubleshoot any issues with the mask, the humidifier, etc. They will also measure End-tidal CO2 via nasal cannula.
|
Other: Vivify
A telemedicine kit will (Vivify) which will obtain daily biometrics (vital signs) and care plans. These are all monitored by the Pulmonary team remotely via an online portal. The telemedicine system has a set-up for alerts whenever there are clinical concerns (vital signs out of parameters), or non-use of the Non-invasive positive pressure ventilation (NIPPV). This system allows for video conferencing between the Pulmonary team (physician, respiratory therapist, nurse) to troubleshoot issues, and increase NIPPV compliance. Other: EMS Emergency medical service scheduled home visits for face to face troubleshooting of the NIPPV, environmental check and end-tidal CO2. |
|
Active Comparator: Vivify Only
This group will receive the telemedicine tablet and kit, with the same protocol as defined above. No EMS home visits will be set up |
Other: Vivify
A telemedicine kit will (Vivify) which will obtain daily biometrics (vital signs) and care plans. These are all monitored by the Pulmonary team remotely via an online portal. The telemedicine system has a set-up for alerts whenever there are clinical concerns (vital signs out of parameters), or non-use of the Non-invasive positive pressure ventilation (NIPPV). This system allows for video conferencing between the Pulmonary team (physician, respiratory therapist, nurse) to troubleshoot issues, and increase NIPPV compliance. |
- 30-day ED and Hospital readmission Rate [ Time Frame: 30 days ]Patients are followed from enrollment for the next 30 days. We will compare rate of re-admissions between the 2 parallel intervention arms, and check the p-value
- SF-12 questionnaire [ Time Frame: every 2 weeks for duration of 6 weeks ]The SF-12 questionnaire gives an assessment score of subject's mental and physician functioning and overall health-related quality of life. We will compare scores of subjects in the parallel intervention groups
- NIV compliance [ Time Frame: 6 weeks ]This is a YES or NO determination of NIV compliance using the CMS (Centers of Medicare and Medicaid) criteria of at least 4hrs use of NIV per day, at least 70% of a 30-day period. We will compare the number of compliant against non-compliant subjects in the 2 parallel intervention groups
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adult patients > 18 years of age
- Evidence of hypercapnia (PCO2 ≥ 45mmHg) secondary to COPD-OSA overlap, OHS, Neuromuscular disease / weakness
- Requiring NIV / NIPPV outpatient
- Ability to operate a smart device / tablet
- Informed consent
Exclusion Criteria:
- Non-English or Non-Spanish- speaking (device videos and surveys are available in English or Spanish only)
- Patients unable to give consent
- Pregnant women
- Prisoners
- Patients <18 years of age
- Patient already on NIPPV/ CPAP at home and compliant on therapy
- Significant non-pulmonary conditions (CHF with EF < 40%), Pulmonary hypertension with PASP> 60 mmGH, severe valvular heart disease, end-stage renal disease or end-stage liver disease.
- Patients without health insurance
- Residing out of state (Pennsylvania)
- Patients with current or history of drug / narcotic dependence
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03353064
| United States, Pennsylvania | |
| Albert Einstein Healthcare Network | |
| Philadelphia, Pennsylvania, United States, 19140 | |
| Principal Investigator: | Sunil Sharma | Albert Einstein Medical Center |
Other Publications:
| Responsible Party: | Sunil Sharma, Division Chair and Program Director of Pulmonary, Critical Care, Allergy and Sleep Medicine, Albert Einstein Healthcare Network |
| ClinicalTrials.gov Identifier: | NCT03353064 |
| Other Study ID Numbers: |
ETOUCH Study |
| First Posted: | November 27, 2017 Key Record Dates |
| Last Update Posted: | October 29, 2018 |
| Last Verified: | October 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Obesity Hypoventilation Syndrome Obesity Lung Diseases, Obstructive Pulmonary Disease, Chronic Obstructive Respiratory Insufficiency Sleep Apnea Syndromes Hypoventilation Neuromuscular Diseases Lung Diseases Respiratory Tract Diseases |
Respiration Disorders Apnea Sleep Disorders, Intrinsic Dyssomnias Sleep Wake Disorders Nervous System Diseases Signs and Symptoms, Respiratory Sleep Apnea, Obstructive Overnutrition Nutrition Disorders |